NCT04134169View on ClinicalTrials.gov

Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)

RecruitingOBSERVATIONAL

Enrollment

28

Participants

Timeline

Start Date

October 2, 2019

Primary Completion Date

August 11, 2025

Study Completion Date

April 11, 2026

Conditions

Rheumatoid Arthritis

Interventions

OTHER

Not applicable(observational study)

Not applicable(observational study)

Trial Locations (1)

Unknown

RECRUITING

Seoul national University Boramae medical center, Seoul

All Listed Sponsors

lead

Kang Stem Biotech Co., Ltd.

INDUSTRY